The most comprehensive and go-to place for all short selling reseach reports online.
Currently a total of 275 research reports from 14 investment research firms has been aggregated, with new reports being added and updated constantly
ALL
Fuzzy Panda Research(8)
Hindenburg Research(52)
MuddyWaters(44)
Blue Orca Capital(35)
Gotham City Research LLC(11)
Anonymous Analytics(5)
J Capital Research(26)
Grizzly Research LLC(22)
Jehoshaphat Research(10)
Culper Research(20)
Ningi Research(4)
Night Market Research(14)
Ontake Research(2)
Bonitas Research(22)
ALL
0067(1)
0607(1)
0773(1)
1044(1)
1228(1)
1259(1)
1360(6)
1619(1)
1636(1)
1717(1)
1910(1)
1999(1)
2018(1)
2020(1)
2200(1)
3823(1)
3836(1)
3998(1)
404(1)
4587(1)
496(1)
555(1)
6186(1)
6594(1)
669.HK(1)
6863(1)
8207(2)
867(1)
ACB(1)
ACMR(1)
AGFY(1)
AHCO(1)
AHG(1)
AMEH(1)
AMT(1)
AMTX(1)
AOS(1)
APHA(1)
AR4(1)
AR4.DE(1)
ARMC(1)
ARRY(1)
ATEC(1)
ATER(1)
ATRC(1)
BCOR(1)
BDSI(1)
BE(1)
BEKE(1)
BGNE(1)
BLA(1)
BLNK(1)
BOO(1)
BRP(1)
BTBT(1)
BTCM(1)
BUR(1)
BWXT(1)
BYSI(1)
CBAT(1)
CCME(1)
CCRC(1)
CDXC(1)
CELH(1)
CGN(1)
CLOV(1)
CLSK(1)
CMC(1)
CMED(1)
CO(1)
CORT(1)
CORZ(1)
CRIUF(1)
CRMD(1)
CRTO(1)
CSSE(1)
CYDY(1)
DATS(1)
DGW(1)
DKNG(1)
DNMR(1)
DOS(1)
DOYU(1)
DVA(1)
EBIX(1)
EBON(1)
EDU(1)
EHTH(1)
EIGU(1)
ELMS(1)
EMO(1)
ENOB(1)
ENPH(1)
EROS(1)
EVER(1)
EVGO(1)
FANH(1)
FCEL(1)
FD(1)
FFIE(1)
FIZZ(1)
FMCN(1)
FRGT(1)
FRSX(1)
FUV(1)
GAU(1)
GDS(2)
GFRE(1)
GGR(1)
GNPX(1)
GNUS(1)
GNW(1)
GOTU(2)
GOW(1)
GRWG(1)
GWH(2)
HASI(2)
HFFG(1)
HMBL(1)
HPR(1)
HROW(2)
HTHT(1)
HYLN(1)
HYZN(1)
IBAT(1)
IDEX(2)
IIPR(1)
INGN(1)
INPX(1)
INS(1)
IPO(1)
IQE(1)
ITP(1)
JCOM(1)
JD(1)
JKS(1)
KERN(1)
KIDS(1)
KNDI(1)
KRZ(1)
LICY(1)
LK(1)
LKE(1)
LKM(1)
LLEN(1)
LMFD(1)
LMND(1)
LOOP(1)
LTS(1)
LX(1)
MARA(2)
MARK(1)
MDCA(1)
MED(1)
MFC(1)
MNSO(1)
MP(2)
MPLN(1)
MULN(1)
MVMD(1)
MXL(1)
N/A(1)
NAK(1)
NB2(1)
NBEV(1)
NEA(1)
NEWP(1)
NEXCF(1)
NG(1)
NIO(1)
NISN(1)
NKLA(1)
NMC(1)
NNOX(1)
NOBGY(1)
NRGV(1)
NTRA(1)
NYMX(1)
OLAG(1)
ONDS(1)
OPK(1)
OPRA(1)
ORA(1)
OSIS(1)
OTRK(1)
PCLO(1)
PCYO(1)
PETS(1)
PGLC(1)
PGNY(1)
PKK(1)
PLL(2)
PLSE(1)
PLTK(1)
PRED(1)
PRTA(1)
PUMP(1)
PVBC(1)
QPP(1)
RFF(1)
RIDE(1)
RINO(1)
RIOT(1)
ROLTA(1)
RUN(1)
S30(1)
SAX(1)
SDC(1)
SEK(1)
SEV(1)
SGLY(1)
SKYS(1)
SLI(2)
SOL(1)
SOS(1)
SPI(1)
SPRD(1)
SRNE(2)
SSTI(1)
STAA(1)
STEM(1)
STJ(1)
SY(1)
TAL(1)
TELIA(1)
TFC(1)
TGLS(1)
TMC(1)
TMCI(1)
TRE(1)
TRUL(1)
TSP(1)
TTSH(1)
TWTR(1)
UAVS(1)
UNH(1)
UTA(1)
VBIV(1)
VERI(1)
VERU(1)
VIEW(1)
WELL(1)
WINS(1)
WKHS(1)
WORX(1)
WTC(1)
WU(1)
WUBA(1)
XL(1)
XMTR(1)
XXII(1)
YMM(1)
YRIV(1)
YY(1)
ZEN(1)
ZNOG(1)
ZTO(1)
ZYXI(1)
Current Share Price: 1.760
J Capital Research
Initial Report Date（2021/06/24）Share Price:9.140
Initial Report Date（2021/06/24）Share Price:9.140
Unhealthy A Full Dose of Promotion
Details Link > After months of examining ChromaDex (CDXC),
we have come to the conclusion that the company is pure hype, dished up by an Oceans 11 of
stock promoters. CDXC promotes its single product,
a health supplement, with iterative press releases
that boost share price long enough for insider sales
before the vaunted advantages contained in those
press releases quietly disappear.
By wantattse
Start
